Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Toremifene Citrate
Therapeutic Area : Undisclosed
Study Phase : Phase III
Sponsor : Ipsen
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Toremifene is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of undefined medical condition.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
October 05, 2010
Lead Product(s) : Toremifene Citrate
Therapeutic Area : Undisclosed
Highest Development Status : Phase III
Sponsor : Ipsen
Deal Size : Inapplicable
Deal Type : Inapplicable